Glofitamab Alternatives Compared
Glofitamab | Prednisone | Rituximab |
|
---|
Glofitamab | Prednisone | Rituximab |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Diffuse Large B-Cell Lymphoma. Glofitamab may also be used for purposes not listed in this medication guide. |
Prescription only
Prednisone effectively controls inflammation and an overactive immune system but may not be suitable for everybody. Long-term use is limited by potentially severe side effects such as adrenal... View more |
Prescription only
Rituximab (brand name Rituxan) is a CD20 monoclonal antibody that causes B-cells to self-destruct or disintegrate and may be used to treat Non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia... View more |
Related suggestions Diffuse Large B-Cell Lymphoma
|
|||||||
More about Glofitamab | More about Prednisone | More about Rituximab | ||||||||
Ratings & Reviews | ||||||||||
Glofitamab has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Prednisone has an average rating of 7.5 out of 10 from a total of 869 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 17% reported a negative effect. |
Rituximab has an average rating of 7.7 out of 10 from a total of 171 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
View all Glofitamab side effects |
View all Prednisone side effects |
View all Rituximab side effects |
||||||||
Drug Class | ||||||||||
Generic Availability | ||||||||||
N/A |
Lower cost generic |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Prednisone prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | ||||||||||
N/A |
|
N/A |
||||||||
Brand Names | ||||||||||
Columvi | Rayos | Riabni, Rituxan, Ruxience, Truxima | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
182.4 hours |
4 hours |
59.8 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
Excluding First Trimester
Category D
Positive evidence of risk
First Trimester See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 380 drugs are known to interact with Glofitamab:
|
A total of 625 drugs are known to interact with Prednisone:
|
A total of 192 drugs are known to interact with Rituximab:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
|
||||||||||
First Approval Date | ||||||||||
June 15, 2023 |
February 21, 1955 |
N/A |
||||||||
WADA Class View classifications | ||||||||||
N/A |
N/A |
|||||||||
More Information | ||||||||||
Patient Resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
|
|
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Monjuvi
Monjuvi (tafasitamab-cxix) is used for the treatment of relapsed or refractory diffuse large B-cell ...
Kymriah
Kymriah is used to treat acute lymphoblastic leukemia (ALL) that is relapsing or refractory in ...
Yescarta
Yescarta is used to treat large B-cell lymphoma and follicular lymphoma, two types of non-Hodgkin ...
Breyanzi
Breyanzi is a CAR T cell therapy for large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle ...
Polivy
Polivy (polatuzumab vedotin-piiq) is a targeted treatment that may be used to treat diffuse large ...
Xpovio
Xpovio is used to treat multiple myeloma (MM) or relapsed/refractory diffuse large B-cell lymphoma ...
Lunsumio
Lunsumio (mosunetuzumab-axgb) is used for the treatment of relapsed or refractory follicular ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.